Abstract: Disclosed is an analog-to-digital converter including a comparison circuit and a counter circuit. The comparison circuit outputs a comparison result signal based on a pixel signal and a ramp signal and outputs a zero-crossing prediction signal, is the comparison circuit being configured to transition the zero-crossing prediction signal before a zero-crossing time point at which a voltage level of the pixel signal becomes identical to a voltage level of the ramp signal and during a time interval during which the voltage level of the ramp signal is reduced. The counter circuit outputs a low-order bit digital code based on the zero-crossing prediction signal and stops the output of the low-order bit digital code based on the comparison result signal.

Abstract: Provided are diagnosis and treatment methods of autism spectrum disorder, based on an activity regulation mechanism of quiescent neural stem cells, and use thereof.

Abstract: A memory system includes a memory device including a memory cell array divided into a plurality of memory banks, and a memory controller that sends read requests or write requests to the memory device for the purpose of inputting data to or outputting data from the memory banks of the memory cell array, respectively, and sends the read requests so as to be separated from the write requests based on a read-write switching point. In a first turn, the memory controller sets a near switching point before the read-write switching point. The memory controller blocks scheduling at least one of first bank requests, between the near switching point and the read-write switching point. The memory controller schedules at least one of second bank requests, which cause state switching of the memory banks, so as to be issued between the near switching point and the read-write switching point.

Abstract: Disclosed is an analog-to-digital converter including a comparison circuit and a counter circuit. The comparison circuit outputs a comparison result signal based on a pixel signal and a ramp signal and outputs a zero-crossing prediction signal, is the comparison circuit being configured to transition the zero-crossing prediction signal before a zero-crossing time point at which a voltage level of the pixel signal becomes identical to a voltage level of the ramp signal and during a time interval during which the voltage level of the ramp signal is reduced. The counter circuit outputs a low-order bit digital code based on the zero-crossing prediction signal and stops the output of the low-order bit digital code based on the comparison result signal.

Abstract: The present disclosure relates to an anode electrode active material for a secondary battery containing nickel cobalt molybdenum oxide, an anode electrode for a secondary battery including the same, a secondary battery including the anode electrode for a secondary battery, and a method for manufacturing the same. The novel anode electrode material for a sodium secondary battery containing nickel cobalt molybdenum oxide according to the present disclosure allows intercalation/deintercalation reaction of sodium ion during charge/discharge and does not undergo significant volume change during the intercalation reaction because structure is maintained stably during repeated charge/discharge. As a result, electrode damage and electric short circuit are decreased and, thus, improved electrochemical characteristics can be achieved in long-life and high-rate capability.

Abstract: The present disclosure relates to an anode electrode active material for a secondary battery containing nickel cobalt molybdenum oxide, an anode electrode for a secondary battery including the same, a secondary battery including the anode electrode for a secondary battery, and a method for manufacturing the same. The novel anode electrode material for a sodium secondary battery containing nickel cobalt molybdenum oxide according to the present disclosure allows intercalation/deintercalation reaction of sodium ion during charge/discharge and does not undergo significant volume change during the intercalation reaction because structure is maintained stably during repeated charge/discharge. As a result, electrode damage and electric short circuit are decreased and, thus, improved electrochemical characteristics can be achieved in long-life and high-rate capability.

Abstract: The disclosure relates to a pre-5th-generation (5G) or 5G communication system to be provided for supporting higher data rates beyond 4th-generation (4G) communication system such as long term evolution (LTE). An operation method of a device for upconversion in a wireless communication system is provided. The method includes receiving a first local oscillator (LO) signal, generating a second LO signal, based on the first LO signal and cross-coupled latches, receiving an input signal, generating an upconverted frequency, based on the second LO signal and the input signal, generating an output signal obtained by processing a harmonic component included in the upconverted frequency, and transmitting the generated output signal.

Abstract: A method of measuring an interaction force includes: generating feature maps corresponding to a plurality of sequential images; generating pooling maps respectively corresponding to feature map groups including a predetermined number of feature maps among the feature maps; generating attention maps corresponding to the pooling maps; and sequentially receiving feature maps modified based on the attention maps and outputting interaction force information.

Abstract: Disclosed is an electronic device for performing code-based encryption supporting integrity verification of a message and an operating method thereof. When a data transmission side encrypts a message through code-based encryption and transmits the encrypted message to a data reception apparatus, the data transmission side is allowed to use a hash value generated based on a part of the message as an error in code-based encryption to support the data reception apparatus to verify an integrity of a received message by using the hash value.

Abstract: The present invention relates to a non-viral minicircle vector expressing a SOX gene, a stem cell into which the vector is introduced, a pharmaceutical composition for preventing or treating a cartilage disease, including the stem cell, and a method for constructing the vector. The transformation of mesenchymal stem cells with MC/SOX-Trio or MC/SOX-Duo, which is a non-viral minicircle vector according to the present invention, can completely exclude the necessity of expensive growth factors that have been indispensably used in inducing the differentiation of mesenchymal stem cells into chondrocytes. Accordingly, the mesenchymal stem cells transformed therewith, when implanted in vivo, can differentiate into chondrocytes by themselves, and thus have an advantage capable of simplifying the existing complicated steps of culturing cells to induce differentiation and then transplanting the cells.

Abstract: Provided are a cathode active material, a cathode comprising same, and a secondary battery. The cathode active material contains crystal water and a manganese-based metal oxide and has a first crystal phase having a two-dimensional crystal structure and a second crystal phase having a three-dimensional crystal structure, wherein the three-dimensional crystal structure is formed by the combination of manganese in the manganese-based metal oxide and oxygen in the crystal water.

Abstract: A plant-soil battery includes a plant body, a soil layer in which the plant body is planted, an anode electrode disposed in the soil layer and including microorganisms that degrade glucose discharged from the plant body to generate electrons, and a cathode electrode disposed in the soil layer to receive the electrons. The plant-soil battery is capable of supplying energy for 24 hours a day, is harmless to the environment, can be easily moved and installed, and has an adjustable generating capacity.

Abstract: A stroke diagnosis and prognosis prediction system includes: an image acquisition unit configured so as to receive a plurality of images including at least a part of a human brain; an image alignment unit for aligning the plurality of images on the basis of a standard brain image; a lesion area detection and mapping unit for respectively detecting lesion areas from the plurality of images, and mapping the detected lesion areas so as to generate one mapping image; a matching and correction unit, which scales a mapping image so as to match the same to the standard brain image and performs image correction on the mapping image; a three-dimensional image generation unit storing the mapping image in a three-dimensional data space, thereby generating a three-dimensional lesion image; and a stroke diagnosis unit for diagnosing a stroke on the basis of the three-dimensional lesion image.

Abstract: The present disclosure relates to an anode electrode active material for a secondary battery containing nickel cobalt molybdenum oxide, an anode electrode for a secondary battery including the same, a secondary battery including the anode electrode for a secondary battery, and a method for manufacturing the same. The novel anode electrode material for a sodium secondary battery containing nickel cobalt molybdenum oxide according to the present disclosure allows intercalation/deintercalation reaction of sodium ion during charge/discharge and does not undergo significant volume change during the intercalation reaction because structure is maintained stably during repeated charge/discharge. As a result, electrode damage and electric short circuit are decreased and, thus, improved electrochemical characteristics can be achieved in long-life and high-rate capability.

Abstract: A method of measuring an interaction force includes: generating feature maps corresponding to a plurality of sequential images; generating pooling maps respectively corresponding to feature map groups including a predetermined number of feature maps among the feature maps; generating attention maps corresponding to the pooling maps; and sequentially receiving feature maps modified based on the attention maps and outputting interaction force information.

Abstract: The present invention relates to a novel compound showing leukotriene B4 receptor 2 (BLT2) inhibitory activity and a pharmaceutical composition, for preventing or treating inflammatory diseases, having same as an active ingredient. The inventors identified a novel compound containing BTL2 inhibitory activity, and experimentally confirmed that the present novel compound had an excellent effect on the enhancement of the cancer cell death, on the inhibition of the metastasis and chemotactic mobility, and on the anti-asthma activity. Therefore, the present novel compound can be used as a very effective pharmaceutical component for treating the inflammatory-related diseases.

Abstract: A method of preparing a lithium metal oxide having a nickel oxide layer formed on a surface thereof includes (1) complexing a nickel precursor onto a surface of a lithium metal oxide; and (2) calcining, through a heat treatment, the lithium metal oxide—the surface of which is complexed with the nickel precursor—obtained in step (1).

Abstract: Disclosed is an electronic device for performing code-based encryption supporting integrity verification of a message and an operating method thereof. When a data transmission side encrypts a message through code-based encryption and transmits the encrypted message to a data reception apparatus, the data transmission side is allowed to use a hash value generated based on a part of the message as an error in code-based encryption to support the data reception apparatus to verify an integrity of a received message by using the hash value.

Abstract: The present invention relates to the serine threonine kinase 32C (STK32C) gene relevant to breast cancer and a use thereof, and particularly, to a composition for the diagnosis, prevention, or treatment of breast cancer using the STK32C gene. In the present invention, changes in breast cancer cells according to STK32C gene expression differences were identified, and a breast cancer inhibitory effect according to the inhibition of expression of the STK32C gene and YB-1, which is a substrate protein, were newly verified, and thus target therapies are expected in treatment of breast cancer through more fundamental approaches.

Abstract: The present invention relates to a novel compound showing leukotriene B4 receptor 2 (BLT2) inhibitory activity and a pharmaceutical composition, for preventing or treating inflammatory diseases, having same as an active ingredient. The inventors identified a novel compound containing BTL2 inhibitory activity, and experimentally confirmed that the present novel compound had an excellent effect on the enhancement of the cancer cell death, on the inhibition of the metastasis and chemotactic mobility, and on the anti-asthma activity. Therefore, the present novel compound can be used as a very effective pharmaceutical component for treating the inflammatory-related diseases.